490 related articles for article (PubMed ID: 9000125)
1. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice.
Kitsberg DI; Leder P
Oncogene; 1996 Dec; 13(12):2507-15. PubMed ID: 9000125
[TBL] [Abstract][Full Text] [Related]
2. Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice.
Lane TF; Leder P
Oncogene; 1997 Oct; 15(18):2133-44. PubMed ID: 9393971
[TBL] [Abstract][Full Text] [Related]
3. MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia.
Daphna-Iken D; Shankar DB; Lawshé A; Ornitz DM; Shackleford GM; MacArthur CA
Oncogene; 1998 Nov; 17(21):2711-7. PubMed ID: 9840935
[TBL] [Abstract][Full Text] [Related]
4. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
5. Clonal variations among multiple primary mammary tumors and within a tumor of individual mice: insertion mutations of int oncogenes.
Sarkar NH
Virology; 1995 Oct; 212(2):490-9. PubMed ID: 7571419
[TBL] [Abstract][Full Text] [Related]
6. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
[TBL] [Abstract][Full Text] [Related]
7. Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4.
Morini M; Astigiano S; Mora M; Ricotta C; Ferrari N; Mantero S; Levi G; Rossini M; Barbieri O
Oncogene; 2000 Dec; 19(52):6007-14. PubMed ID: 11146552
[TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine phosphatase epsilon increases the risk of mammary hyperplasia and mammary tumors in transgenic mice.
Elson A
Oncogene; 1999 Dec; 18(52):7535-42. PubMed ID: 10602512
[TBL] [Abstract][Full Text] [Related]
9. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.
Kapoun AM; Shackleford GM
Oncogene; 1997 Jun; 14(24):2985-9. PubMed ID: 9205106
[TBL] [Abstract][Full Text] [Related]
10. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.
Gallahan D; Jhappan C; Robinson G; Hennighausen L; Sharp R; Kordon E; Callahan R; Merlino G; Smith GH
Cancer Res; 1996 Apr; 56(8):1775-85. PubMed ID: 8620493
[TBL] [Abstract][Full Text] [Related]
11. Association of hst gene expression with metastatic phenotype in mouse mammary tumors.
Murakami A; Tanaka H; Matsuzawa A
Cell Growth Differ; 1990 May; 1(5):225-31. PubMed ID: 1964796
[TBL] [Abstract][Full Text] [Related]
12. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.
Krane IM; Leder P
Oncogene; 1996 Apr; 12(8):1781-8. PubMed ID: 8622899
[TBL] [Abstract][Full Text] [Related]
13. Nonuniform expression of a mouse mammary tumor virus-driven int-2/Fgf-3 transgene in pregnancy-responsive breast tumors.
Stamp G; Fantl V; Poulsom R; Jamieson S; Smith R; Peters G; Dickson C
Cell Growth Differ; 1992 Dec; 3(12):929-38. PubMed ID: 1335281
[TBL] [Abstract][Full Text] [Related]
14. Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice.
Lee FS; Lane TF; Kuo A; Shackleford GM; Leder P
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2268-72. PubMed ID: 7892260
[TBL] [Abstract][Full Text] [Related]
15. Ectopic vasopressin expression in MMTV-Wnt-1 transgenic mice modifies mammary tumor differentiation and pathology.
Chooi KF; Carter DA; Biswas S; Lightman SL; Ho MY; Murphy D
Cancer Res; 1994 Dec; 54(24):6434-40. PubMed ID: 7987839
[TBL] [Abstract][Full Text] [Related]
16. neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors.
Morrison BW; Leder P
Oncogene; 1994 Dec; 9(12):3417-26. PubMed ID: 7970700
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.
Sacco MG; Barbieri O; Piccini D; Noviello E; Zoppé M; Zucchi I; Frattini A; Villa A; Vezzoni P
Gene Ther; 1998 Mar; 5(3):388-93. PubMed ID: 9614559
[TBL] [Abstract][Full Text] [Related]
18. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
[TBL] [Abstract][Full Text] [Related]
19. Identification of a MMTV insertion mutation within the coding region of the Fgf-3 protooncogene.
Morris DW; Dutra JC
Virology; 1997 Nov; 238(1):161-5. PubMed ID: 9375020
[TBL] [Abstract][Full Text] [Related]
20. Keratinocyte growth factor is a growth factor for mammary epithelium in vivo. The mammary epithelium of lactating rats is resistant to the proliferative action of keratinocyte growth factor.
Ulich TR; Yi ES; Cardiff R; Yin S; Bikhazi N; Biltz R; Morris CF; Pierce GF
Am J Pathol; 1994 May; 144(5):862-8. PubMed ID: 8178937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
